Go to content

You are here:

  • Home
  • ESME news: XMRV Breakthrough - Information Flow in Europe

ESME news: XMRV Breakthrough - Information Flow in Europe

The Scientific Panel, the Board of Directors and the staff of ESME wish to congratulate the Whittemore Peterson Institute on the groundbreaking work they are performing in the area of neuro-immune diseases and especially their work with the XMRV virus. We applaud the thoroughness of your research and the openness with which you are sharing this research information with the world. We believe that by sharing scientific knowledge with this openness, you are starting a new era of scientific cooperation.

Dear Whittemore Peterson Institute,

The Scientific Panel, the Board of Directors and the staff of ESME wish to congratulate the Whittemore Peterson Institute on the groundbreaking work they are performing in the area of neuro-immune diseases and especially their work with the XMRV virus. We applaud the thoroughness of your research and the openness with which you are sharing this research information with the world. We believe that by sharing scientific knowledge with this openness, you are starting a new era of scientific cooperation.

ESME would like to help the Whittemore Peterson Institute with information flow in Europe. We have the capacity to professionally translate information to Danish, Dutch, German, Norwegian, French and Spanish and we have a professional website where information can be posted in any of these languages: www.esme-eu.com.

ESME has also established a database of approximately 3800 e-mail addresses of European scientists, doctors, medical associations, national and regional ME associations, politicians, journalists and other people interested in ME/CFS. This database allows us to easily distribute information to professionals in many fields. We will gladly use our resources to assist the Whittemore Peterson Institute with the distribution of information in Europe.

In 2009, ESME cooperated with the Norwegian ME Association and held two conferences in Norway. The focus of these conferences wasto educate healthcare personnel (and patients) about the diagnostics, treatment, causes and consequences of ME/CFS. ESME will continue working with patient organizations to hold conferences in the coming yearsthroughout Europe. We would like to invite a representative of the WPI to be a guest speaker at future European conferences to help us inform and train European MD’s and therapists better.

For more information about the Norwegian conference in Stavanger, including Dr. De Meirleir’s Power Point Presentation, please go to the Norwegian ME Association’s home page at:  www.me-forening.no.

With Kind Regards,

ESME

www.esme-eu.com